The European Commission initiates an inquiry into Chinese procurement of medical devices, suspecting unfair access for European suppliers. Under the EU International Procurement Instrument, the probe may lead to restrictions on Chinese firms bidding in EU tenders. Allegations include 'Buy China' policies and abnormally low bids. China invited for consultations.
